Civica Rx's Strategy To Reduce Drug Shortages Focuses On Guaranteed-Price Contracts
Executive Summary
Non-profit intermediary being built by hospitals and health systems offers a private sector response to one of the deterrents to adequate supplies of important older generic drugs.
You may also be interested in...
While There's No Easy Rx for Drug Shortages, Pharma Groups Have Some Ideas
Industry groups suggest that the drug shortage crisis needs to be addressed by changing the economic model for reimbursement, while US FDA can help by making it easier for manufacturers to use “standby” facilities as needed to bridge supply gaps and by providing generic drug manufacturers with more notice on when applications will be approved.
It’s Time For The Feds To Get Into Drug Manufacturing, Senator Warren Says
Warren's proposed legislation aims to bring down prices and stabilize supplies by establishing government competition to generic drug monopolies.
Cleveland Clinic “Outsourcing”? 503B Status Would Be Milestone For US FDA’s Compounding Model
Chronic problem with drug shortages is driving the Cleveland Clinic to consider registering as a 503B “outsourcing” facility. That could be a milestone in FDA’s efforts to encourage the model for high volume compounders.